Streetbeat News

Analyst Ratings

BLCO

Evercore ISI Group has maintained an 'In-Line' rating for Bausch & Lomb (NYSE:BLCO) and raised its price target from $17 to $19.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 4:18 pm

BAX

Citigroup analyst Joanne Wuensch maintains a Neutral rating on Baxter Intl (NYSE:BAX) and raises the price target from $38 to $40.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 4:17 pm

BDX

Evercore ISI Group has maintained an 'Outperform' rating on Becton Dickinson (NYSE:BDX) and raised its price target from $286 to $290.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 4:16 pm

STTK

HC Wainwright & Co. has downgraded Shattuck Labs (NASDAQ:STTK) from Buy to Neutral, as per analyst Joseph Pantginis.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 4:16 pm

TXRH

Citigroup analyst Jon Tower maintains a Buy rating on Texas Roadhouse and raises the price target from $192 to $201.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 4:15 pm

AZTA

Evercore ISI Group has maintained an In-Line rating on Azenta (NASDAQ:AZTA) while lowering the price target from $53 to $50.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 4:14 pm

ARCT

HC Wainwright & Co. has reiterated its Buy rating for Arcturus Therapeutics, maintaining a price target of $63.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 4:12 pm

ABT

Evercore ISI Group has maintained an 'Outperform' rating on Abbott Laboratories and raised its price target from $120 to $124.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 4:11 pm

A

Evercore ISI Group analyst Vijay Kumar maintains an In-Line rating on Agilent Technologies and raises the price target from $135 to $145.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 4:09 pm

LTM

LATAM Airlines Group SA (NYSE:LTM) has been rated 'Overweight' by Morgan Stanley analyst Jens Spiess, with a price target of $40. Despite a 55% drop in share price since pre-pandemic levels, the company is seen as offering growth at an attractive price, with profitability above pre-COVID-19 levels. The analyst expects earnings to remain high and highlights the company's exposure to under-penetrated markets as a growth driver.

Portfolio Pulse from Priya Nigam

October 01, 2024 | 4:05 pm